Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Salix Pharmaceuticals (SLXP): Q2 EPS of $0.79 beats by $0.25. Revenue of $181M (+36% Y/Y)...

  • Wednesday, August 8, 2012, 5:28 PM ET
    Salix Pharmaceuticals (SLXP): Q2 EPS of $0.79 beats by $0.25. Revenue of $181M (+36% Y/Y) in-line. Shares +9.4% AH. (PR)
Other date
DJIA (DIA) S&P 500 (SPY)